[go: up one dir, main page]

AU6295094A - Compositions for the treatment of eye diseases - Google Patents

Compositions for the treatment of eye diseases

Info

Publication number
AU6295094A
AU6295094A AU62950/94A AU6295094A AU6295094A AU 6295094 A AU6295094 A AU 6295094A AU 62950/94 A AU62950/94 A AU 62950/94A AU 6295094 A AU6295094 A AU 6295094A AU 6295094 A AU6295094 A AU 6295094A
Authority
AU
Australia
Prior art keywords
compositions
treatment
eye diseases
diseases
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62950/94A
Inventor
Alica Huxley
Georg Mathis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ciba Vision AG
Original Assignee
Ciba Vision AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Vision AG filed Critical Ciba Vision AG
Publication of AU6295094A publication Critical patent/AU6295094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU62950/94A 1993-03-19 1994-03-17 Compositions for the treatment of eye diseases Abandoned AU6295094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP93810199 1993-03-19
EP93810199 1993-03-19
PCT/SK1994/000001 WO1994021256A1 (en) 1993-03-19 1994-03-17 Compositions for the treatment of eye diseases

Publications (1)

Publication Number Publication Date
AU6295094A true AU6295094A (en) 1994-10-11

Family

ID=8214935

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62950/94A Abandoned AU6295094A (en) 1993-03-19 1994-03-17 Compositions for the treatment of eye diseases

Country Status (4)

Country Link
AU (1) AU6295094A (en)
IL (1) IL108924A0 (en)
WO (1) WO1994021256A1 (en)
ZA (1) ZA941921B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0236734A3 (en) * 1986-02-07 1988-05-11 Ciba-Geigy Ag 5-Amino-4-hydroxyvaleryl derivatives substituted by s-containing groups
IL90184A0 (en) * 1988-05-09 1989-12-15 Abbott Lab Functionalized peptidyl aminodiols and-triols
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors

Also Published As

Publication number Publication date
IL108924A0 (en) 1994-06-24
WO1994021256A1 (en) 1994-09-29
ZA941921B (en) 1994-09-20

Similar Documents

Publication Publication Date Title
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU7867994A (en) Hemofiltration of mediator-related diseases
AU7545594A (en) Implantable device for the treatment of aedemas
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU6916694A (en) Novel treatments for allergic diseases
AU6801694A (en) The treatment of small animals
AU6253094A (en) Methods for the treatment of osteoporosis
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU5526196A (en) Compositions for the treatment of dandruff
AU3027692A (en) Compositions for the treatment of mammalian diseases
AU5699396A (en) Compositions for the treatment of skin conditions
AU5430894A (en) Diagnosis of eye disorders
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU6301094A (en) The use of compositions for combating tumour diseases
AU8879691A (en) Treatment of dispersions
AU6973194A (en) Composition for ophthalmic use
AU2754997A (en) The treatment of plant diseases
AU6662794A (en) Composition for the treatment of impaired hair growth
AU3722593A (en) Compositions for the treatment of glaucoma
AU5018893A (en) Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
AU6295094A (en) Compositions for the treatment of eye diseases
AU6973094A (en) Composition for ophthalmic use